NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE Drug Patent Profile
✉ Email this page to a colleague
When do Neomycin Sulfate-triamcinolone Acetonide patents expire, and what generic alternatives are available?
Neomycin Sulfate-triamcinolone Acetonide is a drug marketed by Fougera and Pharmaderm and is included in four NDAs.
The generic ingredient in NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE is neomycin sulfate; triamcinolone acetonide. There are nineteen drug master file entries for this compound. Additional details are available on the neomycin sulfate; triamcinolone acetonide profile page.
Summary for NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 4 |
Formulation / Manufacturing: | see details |
DailyMed Link: | NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE
US Patents and Regulatory Information for NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fougera | NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE | neomycin sulfate; triamcinolone acetonide | CREAM;TOPICAL | 062600-001 | Jul 21, 1986 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pharmaderm | NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE | neomycin sulfate; triamcinolone acetonide | OINTMENT;TOPICAL | 062607-001 | May 23, 1986 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pharmaderm | NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE | neomycin sulfate; triamcinolone acetonide | CREAM;TOPICAL | 062595-001 | Jul 21, 1986 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |